TP53 and osteosarcoma: Peng et al. [85] demonstrated that PRIMA-1MET inhibited activity of thioredoxin reductase 1, an important regulator of cell redox balance, and thus, induced cell death through increased oxidation level in lung adenocarcinoma and osteosarcoma cells irrespective of p53 status.